Library
1D-AL-LAD
1D-AL-LAD, also known as 1-(1,2-dimethylcyclobutane-1-carbonyl)-AL-LAD, is a psychedelic drug of the lysergamide family related to AL-LAD. It is thought to be a prodrug of AL-LAD similarly to how 1D-LSD is a prodrug of LSD. 1D-AL-LAD was encountered online as a novel designer drug in 2023 and 2024. It is said to have a dose of 100 to 300 μg orally, a time to peak effects of 2 to 2.5 hours, and a duration of 12 hours. The drug is said have "half the intensity" of LSD, with its effects including psychedelic visuals among others. Although 1D-AL-LAD has reported to have been sold, some or all of the sold product appears to have actually been mislabeled 1T-AL-LAD. 1D-AL-LAD is not an explicitly controlled substance in the United States or in Canada.
Classification
- Chemical: Lysergamide
- Psychoactive: Psychedelic
Effects
- Dilated Pupils
- Pupil Dilation
- Stimulation
- Nausea
- Spontaneous Tactile Sensations
- Physical Euphoria
- Introspection
- Euphoria
- Time Distortion
- Conceptual Thinking
- Novelty Enhancement
- Analysis Enhancement
- Visual Distortions
- Color Enhancement
- Drifting
- Tracers
- Pattern Recognition Enhancement
- Hallucinations
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
